Nanotechnology for Stimulating Osteoprogenitor Differentiation
The Open Orthopaedics Journal · 30.12.2016 · 10 (1) · 849-861
DOI: 10.2174/1874325001610010849 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open Orthopaedics Journal, erschienen am 30.12.2016. Verfasst von A Ibrahim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Great Ormond Street Hospital For Children NHS Trust, London, UK; Stem Cell and Regenerative Medicine Section, UCL Grea…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Bone is the second most transplanted tissue and due to its complex structure, metabolic demands and various functions, current reconstructive options such as foreign body implants and autologous tissue transfer are limited in their ability to restore defects. Most tissue engineering approaches target osteoinduction of osteoprogenitor cells by modifying the extracellular environment, using scaffolds or targeting intracellular signaling mechanisms or commonly a combination of all of these. Whilst there is no consensus as to what is the optimal cell type or approach, nanotechnology has been proposed as a powerful tool to manipulate the biomolecular and physical environment to direct osteoprogenitor cells to induce bone formation.
Methods
Review of the published literature was undertaken to provide an overview of the use of nanotechnology to control osteoprogenitor differentiation and discuss the most recent developments, limitations and future directions.
Results
Nanotechnology can be used to stimulate osteoprogenitor differentiation in a variety of way. We have principally classified research into nanotechnology for bone tissue engineering as generating biomimetic scaffolds, a vector to deliver genes or growth factors to cells or to alter the biophysical environment. A number of studies have shown promising results with regards to directing ostroprogenitor cell differentiation although limitations include a lack of in vivo data and incomplete characterization of engineered bone.
Conclusion
There is increasing evidence that nanotechnology can be used to direct the fate of osteoprogenitor and promote bone formation. Further analysis of the functional properties and long term survival in animal models is required to assess the maturity and clinical potential of this.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic Surgery, Great Ormond Street Hospital For Children NHS Trust, London, UK; Stem Cell and Regenerative Medicine Section, UCL Great Ormond Street Hospital Institute of Child Health, University College…
- Reconstructive Surgery and Regenerative Medicine Research Group, The Welsh Centre for Burns & Plastic Surgery, Swansea, UK; European Centre of Nano Health, Swansea University Medical School, Swansea, UK.
- Department of Plastic Surgery, Great Ormond Street Hospital For Children NHS Trust, London, UK.
- Stem Cell and Regenerative Medicine Section, UCL Great Ormond Street Hospital Institute of Child Health, University College London, UK.
Zitieren
APA
Ibrahim, A., Bulstrode, N. W., Whitaker, I. S., Eastwood, D. M., Dunaway, D., & Ferretti, P. (2016). Nanotechnology for Stimulating Osteoprogenitor Differentiation. The Open Orthopaedics Journal, 10(1), 849-861. https://doi.org/10.2174/1874325001610010849
Vancouver
Ibrahim A, Bulstrode NW, Whitaker IS, Eastwood DM, Dunaway D, Ferretti P. Nanotechnology for Stimulating Osteoprogenitor Differentiation. The Open Orthopaedics Journal. 2016;10(1):849-861. doi:10.2174/1874325001610010849
BibTeX
@article{Ibrahim2016,
author = {Ibrahim, A and Bulstrode, N W and Whitaker, I S and Eastwood, D M and Dunaway, D and Ferretti, P},
title = {Nanotechnology for Stimulating Osteoprogenitor Differentiation},
journal = {The Open Orthopaedics Journal},
year = {2016},
volume = {10},
number = {1},
pages = {849--861},
doi = {10.2174/1874325001610010849}
}
EUVIMED